TheBrief.Health

Bravo CF Recall Requires Removal From Esophageal Testing

Episode Summary

FDA classified the Bravo CF delivery-device recall as Class I, prompting facilities to quarantine affected inventory, review scheduled procedures, and arrange alternative reflux-monitoring options.